Milestone Scientific, Inc. (MLSS) vs Nephros Inc. (NEPH)
Milestone Scientific, Inc. and Nephros Inc. are both Medical Instruments & Supplies companies. Nephros Inc. is the larger, with a market value of $45.0M against $37.2M — 1.2× the size. Milestone Scientific, Inc. has negative trailing earnings, so its P/E is not meaningful; Nephros Inc. trades at 27.2×. Nephros Inc. grew revenue faster over the last twelve months: 24.2% against 3.72%. Nephros Inc. has the higher net margin (8.38% vs −44.0%) and the higher return on invested capital (14.1% vs −136.2%). Across the 18 metrics below, Nephros Inc. leads on 17 and Milestone Scientific, Inc. on 1.
Valuation
Profitability
| Metric | MLSS | NEPH | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 70.23% | 61.26% | 54.62% |
| Operating margin | (43.56%) | 7.92% | 1.64% |
| Net margin | (43.98%) | 8.38% | 0.00% |
| Free cash flow margin | (6.98%) | (3.19%) | 1.61% |
| Return on equity | (121.68%) | 16.10% | 0.00% |
| Return on assets | (50.54%) | 12.39% | 0.00% |
| Return on invested capital | (136.16%) | 14.11% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack